Publications by authors named "Dirk Faict"

Claim this Profile
I
Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.
Filip de Vin, Peter Rutherford, Dirk Faict

Perit Dial Int· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials.
Markus Voges, Jose C Divino-Filho, Dirk Faict, Fabian Somers, Pierre Vermeulen

Perit Dial Int· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of new peritoneal dialysis solutions on leukocyte recruitment in the rat peritoneal membrane.
Siska Mortier, Dirk Faict, Marion Gericke, Norbert Lameire, An De Vriese

Nephron Exp Nephrol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
Mohammad Zareie, Anton A van Lambalgen, Piet M ter Wee, Liesbeth H P Hekking, Eelco D Keuning, Dirk Faict

Perit Dial Int· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model.
Siska Mortier, Dirk Faict, Norbert H Lameire, An S De Vriese

Kidney Int· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of drug additives in peritoneal dialysis solutions in a new container.
Markus Voges, Dirk Faict, Guy Lechien, Michel Taminne

Perit Dial Int· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution.
Wim Van Biesen, Walter Boer, Bart De Greve, Clement Dequidt, Denise Vijt, Dirk Faict

Perit Dial Int· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Siska Mortier, Dirk Faict, Casper G Schalkwijk, Norbert H Lameire, An S De Vriese

Kidney Int· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic administration in an animal model of chronic peritoneal dialysate exposure.
Siska Mortier, An S De Vriese, Anne Leyssens, Nele J Vanacker, Dirk Faict

Perit Dial Int· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo.
Mohammad Zareie, Liesbeth H P Hekking, Angelique G A Welten, Bas A J Driesprong, Inge L Schadee-Eestermans, Dirk Faict

Nephrol Dial Transplant· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal dialysis solution biocompatibility: definitions and evaluation strategies.
Clifford J Holmes, Dirk Faict

Kidney Int Suppl· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Line Skoufos, Nicholas Topley, Laurinda Cooker, Anne Dawnay, David J Millar, Dirk Faict

Kidney Int Suppl· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis.
Max Dratwa, Martin Wilkie, Jean-Philippe Ryckelynck, P M ter Wee, Peter Rutherford, Dirk Faict

Kidney Int Suppl· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.
Kjeld Otte, Maria Theresa Gonzalez, Maria-Auxiliadora Bajo, Gloria del Peso, James Heaf, Dirk Faict

Perit Dial Int· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte-derived dendritic cells: effect of lactate and glucose-degradation products.
Amaya Puig-Kröger, Oscar Muñiz Pello, Oscar Muñiz-Pello, Rafael Selgas, Gabriel Criado, Dirk Faict

J Leukoc Biol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure.
An S De Vriese, Siska Mortier, Maria Cornelissen, Els Palmans, Nele J Vanacker, Dirk Faict

Perit Dial Int· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous dialysis with bicarbonate/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function.
Suzanne Jones, Clifford J Holmes, Ruth K Mackenzie, Rachel Stead, Gerald A Coles, Dirk Faict

J Am Soc Nephrol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution.
Liesbeth H P Hekking, Mohammad Zareie, Bas A J Driesprong, Dirk Faict, Angelique G A Welten

J Am Soc Nephrol· December 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis